Chimeric antigen receptor-modified T cells strike back

Abstract excerpt

Chimeric antigen receptors (CARs) are engineered molecules designed to endow a polyclonal T-cell population with the ability to recognize tumor-associated surface antigens. In their simplest form, CARs comprise a targeting moiety in the form of a single-chain variable fragment from an antibody connected to various intracellular signaling domains allowing for T-cell activation. This powerful approach combines the...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Virus-based gene therapy research
• Share to CAR-T cell therapy research
• Share to Nanowire Synthesis and Applications